Posttranslationally modified self-peptides promote hypertension in mouse models
Nathaniel Bloodworth, Wei Chen, Kuniko Hunter, David Patrick, Amy M. Palubinsky, Elizabeth Phillips, Daniel Roeth, Markus Kalkum, Simon Mallal, Sean Davies, …
The Journal of Clinical Investigation, Vol.134(16), e174374
Posttranslational modifications can enhance immunogenicity of self-proteins. In several conditions, including hypertension, systemic lupus erythematosus, and heart failure, isolevuglandins (IsoLGs) are formed by lipid peroxidation and covalently bond with protein lysine residues. Here, we show that the murine class I major histocompatibility complex (MHC-I) variant H-2Db uniquely presents isoLG-modified peptides and developed a computational pipeline that identifies structural features for MHC-I accommodation of such peptides. We identified isoLG-adducted peptides from renal proteins, including sodium glucose transporter 2, cadherin 16, Kelch domain–containing protein 7A, and solute carrier family 23, that are recognized by CD8+ T cells in tissues of hypertensive mice, induce T cell proliferation in vitro, and prime hypertension after adoptive transfer. Finally, we find patterns of isoLG-adducted antigen restriction in class I human leukocyte antigens that are similar to those in murine analogs. Thus, we have used a combined computational and experimental approach to define likely antigenic peptides in hypertension.
Details
Title
Posttranslationally modified self-peptides promote hypertension in mouse models
Authors/Creators
Nathaniel Bloodworth
Wei Chen
Kuniko Hunter
David Patrick
Amy M. Palubinsky - Vanderbilt University School of Medicine
Elizabeth Phillips
Daniel Roeth
Markus Kalkum
Simon Mallal
Sean Davies
Mingfang Ao
Rocco Moretti
Jens Meiler
David G. Harrison
Publication Details
The Journal of Clinical Investigation, Vol.134(16), e174374